These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
Ontario, Canada
|
|
98-1220792
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
|
|
|
|
|
895 Don Mills Road, Bldg. 2, Suite 900
|
|
|
|
Toronto, Ontario, Canada, M3C 1W3
|
|
|
|
(Address of principal executive offices)
|
|
|
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
|
Common Shares
|
ANY
|
NASDAQ Capital Market
|
|
|
|
|
|
Page
|
|
Item 1.
|
Business
|
|
|
Item 1A.
|
Risk Factors
|
|
|
Item 1B.
|
Unresolved Staff Comments
|
|
|
Item 2.
|
Properties
|
|
|
Item 3.
|
Legal Proceedings
|
|
|
Item 4.
|
Mine Safety Disclosures
|
|
|
Item 5.
|
Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities
|
|
|
Item 6.
|
Selected Financial Data
|
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
|
Item 9A.
|
Controls and Procedures
|
|
|
Item 9B.
|
Other Information
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
|
Item 11.
|
Executive Compensation
|
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
|
Item 13.
|
Certain Relationship and Related Transactions, and Director Independence
|
|
|
Item 14.
|
Principal Accounting Fees and Services
|
|
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
|
|
Item 16.
|
Form 10-K Summary
|
|
|
SIGNATURES
|
||
|
•
|
The HVE-STACK high density server provides the computer and storage appliance for the data center and is ideal for high performance computing, cloud computing and virtual desktop infrastructure (“VDI”). The modular design and swappable components include hard drives and power supplies intended to improve the efficiency of data center deployment.
|
|
•
|
The HVE-VELOCITY High Availability Dual Enclosure storage area network (“SAN”) provides data reliability and integrity for optimal data storage, protection and recovery. It also provides a unified network attached storage (“NAS”) and SAN solution with thin provisioning, compression and deduplication. The HVE-VELOCITY platform is designed to eliminate single points of failure. The 12GSAS SSD design allows for faster access to data. It is optimized for mission-critical, enterprise-level storage applications.
|
|
•
|
The HVE 3DGFX is a VDI solution that offers hardware and software technologies to provide an appliance that can handle from eight to up to 128 high demand users in a single 2U appliance. The HVE 3DGFX was designed and engineered as a purpose-built solution based upon the MSRP engineering approach.
|
|
•
|
The SnapServer
®
XSR40 is a 1U server that can be configured with up to four SATA III and SSD drives, and can scale to 400 TB of storage capacity by adding up to three SnapExpansion XSR
™
enclosures.
|
|
•
|
The SnapServer
®
XSR120 is a 2U server that can be configured with up to 12 SATA III, SAS and SSD drives, and can scale to 960 TB of storage capacity by adding up to seven SnapExpansion XSR
™
enclosures.
|
|
•
|
Disk Systems - RDX
®
Removable Disk Solutions
|
|
•
|
Tape Automation Systems - NEO
®
Tape-Based Backup and Long-Term Archive Solutions
|
|
•
|
Tape Drives and Media
|
|
•
|
Distribution channel
-
We have distribution partners in North America. We sell through a two-tier distribution model where distributors sell our products to system integrators, value-added resellers (“VARs”) or direct market resellers (“DMRs”), who in turn sell to end users. We support these distribution partners through our dedicated sales force and engineers. In 2019, two distribution partners accounted for, in the aggregate, 24.5% of net revenue.
|
|
•
|
Reseller channel
-
Our worldwide reseller channel includes systems integrators, VARs and DMRs. Our resellers may package our products as part of complete application and desktop virtualization solutions data processing systems or with other storage devices to deliver complete enterprise information technology infrastructure solutions. Our resellers also recommend our products as replacement solutions when systems are upgraded, or bundle our products with storage management software specific to the end user’s system. We support the reseller channel through our dedicated sales representatives, engineers and technical support organizations.
|
|
•
|
Cloud Marketplace
-
Since 2015, we have utilized the Microsoft Azure Cloud Marketplace as an additional channel for our cloud solutions to sell to end-users directly with the pay-per-use model, supported through the Microsoft Azure Cloud.
|
|
•
|
build or leverage, as applicable, a network of channel partners to create an expanding presence in the evolving marketplace for our products and services;
|
|
•
|
build or leverage, as applicable, a sales team to keep end-users and channel partners informed regarding the technical features, issues and key selling points of our products and services;
|
|
•
|
attract and retain qualified technical personnel in order to continue to develop reliable and flexible products and provide services that respond to evolving customer needs;
|
|
•
|
develop support capacity for end-users as sales increase, so that we can provide post-sales support without diverting resources from product development efforts; and
|
|
•
|
expand our internal management and financial controls significantly, so that we can maintain control over our operations and provide support to other functional areas as the number of personnel and size increases.
|
|
•
|
varying size, timing and contractual terms of orders for our products, which may delay the recognition of revenue;
|
|
•
|
competitive conditions in the industry, including strategic initiatives by us or our competitors, new products or services, product or service announcements and changes in pricing policy by us or our competitors;
|
|
•
|
market acceptance of our products and services;
|
|
•
|
our ability to maintain existing relationships and to create new relationships with channel partners;
|
|
•
|
the discretionary nature of purchase and budget cycles of our customers and end-users;
|
|
•
|
the length and variability of the sales cycles for our products;
|
|
•
|
general weakening of the economy resulting in a decrease in the overall demand for our products and services or otherwise affecting the capital investment levels of businesses with respect to our products or services;
|
|
•
|
timing of product development and new product initiatives;
|
|
•
|
changes in customer mix;
|
|
•
|
increases in the cost of, or limitations on, the availability of materials;
|
|
•
|
fluctuations in average selling prices;
|
|
•
|
changes in product mix; and
|
|
•
|
increases in costs and expenses associated with the introduction of new products.
|
|
•
|
a change in competitive strategy that adversely affects a distributor’s or reseller’s willingness or ability to stock and distribute our products;
|
|
•
|
the reduction, delay or cancellation of orders or the return of a significant amount of our products;
|
|
•
|
the loss of one or more of our distributors or resellers; and
|
|
•
|
any financial difficulties of our distributors or resellers that result in their inability to pay amounts owed to us.
|
|
•
|
diversion of management’s attention;
|
|
•
|
disruption to our ongoing business;
|
|
•
|
failure to retain key acquired personnel;
|
|
•
|
difficulties in integrating acquired operations, technologies, products or personnel;
|
|
•
|
unanticipated expenses, events or circumstances;
|
|
•
|
assumption of disclosed and undisclosed liabilities; and
|
|
•
|
inappropriate valuation of the acquired in-process research and development, or the entire acquired business.
|
|
•
|
divert the attention of our management, cause significant delays, materially disrupt the conduct of our business or materially adversely affect our revenue, financial condition and results of operations;
|
|
•
|
be time consuming to evaluate and defend;
|
|
•
|
result in costly litigation and substantial expenses;
|
|
•
|
cause product shipment delays or stoppages;
|
|
•
|
subject us to significant liabilities;
|
|
•
|
require us to enter into costly royalty or licensing agreements;
|
|
•
|
require us to modify or stop using the infringing technology; or
|
|
•
|
result in costs or other consequences that have a material adverse effect on our business, results of operations and financial condition.
|
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
|
•
|
volatility in the market prices and trading volumes of technology stocks;
|
|
•
|
changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular;
|
|
•
|
future capital raising activities;
|
|
•
|
sales of common shares by holders thereof or by us;
|
|
•
|
failure of securities analysts to maintain coverage of Sphere 3D, changes in financial estimates by securities analysts who follow Sphere 3D, or our failure to meet these estimates or the expectations of investors;
|
|
•
|
the financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;
|
|
•
|
market acceptance of our products and technologies;
|
|
•
|
announcements by us or our competitors of new products or services;
|
|
•
|
the public’s reaction to our press releases, other public announcements and filings with the SEC and the applicable Canadian securities regulatory authorities;
|
|
•
|
rumors and market speculation involving us or other companies in our industry;
|
|
•
|
actual or anticipated changes in our operating results or fluctuations in our operating results;
|
|
•
|
actual or anticipated developments in our business, our competitors’ businesses or the competitive landscape generally;
|
|
•
|
litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;
|
|
•
|
developments or disputes concerning our intellectual property or other proprietary rights;
|
|
•
|
announced or completed acquisitions of businesses or technologies by us or our competitors;
|
|
•
|
new laws or regulations or new interpretations of existing laws or regulations applicable to us and our business;
|
|
•
|
changes in accounting standards, policies, guidelines, interpretations or principles;
|
|
•
|
any significant change in our executive officers and other key personnel or Board of Directors;
|
|
•
|
general economic conditions and slow or negative growth of our markets;
|
|
•
|
release of transfer restrictions on certain outstanding common shares; and
|
|
•
|
news reports relating to trends, concerns or competitive developments, regulatory changes and other related issues in our industry or target markets.
|
|
|
|
2019
|
|
2018
|
||||
|
|
|
High
|
|
Low
|
|
High
|
|
Low
|
|
First Quarter
|
|
$4.00
|
|
$2.35
|
|
$24.32
|
|
$7.00
|
|
Second Quarter
|
|
$3.12
|
|
$1.42
|
|
$9.12
|
|
$2.56
|
|
Third Quarter
|
|
$2.08
|
|
$1.00
|
|
$5.76
|
|
$1.06
|
|
Fourth Quarter
|
|
$1.55
|
|
$0.66
|
|
$8.70
|
|
$1.52
|
|
•
|
On May 6, 2020, the Company filed of articles of amendment to create a fourth series of preferred shares, being, an unlimited number of Series D Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. The Series D Preferred Shares are convertible into our common shares, at a conversion price equal to $0.65, subject to certain anti-dilution adjustments. Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than 800,000 common shares by all holders of Series D Preferred Shares. The Series D Preferred Shares do not have voting rights.
|
|
•
|
On April 30, 2020, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with two investors (the “Purchasers“) relating to the issuance and sale, in the aggregate, 1,694,000 shares (the “Shares“) of the Company's to be established Series D Convertible Preferred Stock, no par value and warrants to purchase up to 1,694,000 common shares of the Company in a private placement transaction, in exchange for the assignment to the Company by the investors of certain promissory notes receivable held by the investors in an aggregate amount of $1.1 million. The sale of the Shares to the Purchasers closed on May 6, 2020 (the “Closing“). Subject to certain limitations, the warrants will be exercisable commencing on the six month anniversary of the Closing at an exercise price equal to $0.92 per common share, subject to adjustments as provided under the terms of the warrants. This transaction combined with the conversion of the below convertible debentures, which were both completed after the reporting period, have increased the Company’s equity balance by adding approximately $1.5 million to the equity balance that was reported as of December 31, 2019.
|
|
•
|
Between April 7, 2020 and April 24, 2020, the Company converted
$377,000
of convertible debentures and issued
580,580
common shares of the Company, of which
271,040
common shares were issued to related parties.
|
|
•
|
On April 21, 2020, two investors, one of which was an investor of the March 23, 2020 Offering, entered into share purchase agreements to acquire 330,000 common shares of the Company. As a result of this transaction, the investor participating in the Offering will hold enough common shares be classified as a related party of the Company. Originally, the common shares were held by a vendor of the Company subject to the October 2019 related party subscription agreement the Company entered into with such vendor and issued 330,000 common shares of the Company at $1.07 per share to the vendor in exchange for the satisfaction of certain accounts payable. In the second quarter of 2020, the aggregate amount of the obligations owed by the Company to the vendor were reduced by $157,000, the actual cash proceeds received by the vendor from the share purchase agreements.
|
|
•
|
On April 9, 2020, the Company received loan proceeds in the amount of
$667,400
(the “PPP Funds”) and entered into a loan agreement with City National Bank pursuant to the CARES Act. The CARES Act was established in order to enable small businesses to pay employees during the economic slowdown caused by COVID-19 by providing forgivable loans to qualifying businesses for up to 2.5 times their average monthly payroll costs. The amount borrowed by the Company under the CARES Act is eligible to be forgiven provided that (a) the Company uses the PPP Funds during the eight week period after receipt thereof, and (b) the PPP Funds are only used to cover payroll costs (including benefits), rent, mortgage interest, and utility costs. The amount of loan forgiveness will be reduced if, among other reasons, the Company does not maintain staffing or payroll levels. Principal and interest payments on any unforgiven portion of the PPP Funds (the “PPP Loan”) will be deferred for six months and will accrue interest at a fixed annual rate of
1.0%
and carry a two year maturity date. There is no prepayment penalty on the CARES Act Loan.
|
|
•
|
On March 23, 2020, the Company entered into subscription agreements by and among the Company and the investors party thereto, including Torrington Financial Services Ltd (the “Advisor”), for the purchase and sale of 725 units (collectively, the “Units” and individually, a “Unit”) for aggregate gross proceeds of up to $725,000 (the “Offering”), with each Unit consisting of (a) a 6% convertible debenture in the principal amount of $1,000, which is convertible at $0.6495 per share into 1,540 common shares of the Company, and (b) a warrant to purchase 1,540 common shares of the Company exercisable at any time on or before the third year anniversary date at an exercise price of $0.60 per share. The warrant includes a provision restricting the warrant holder from exercising it if the aggregate number of common shares held by the warrant holder equals or exceeds 5.0% of the issued and outstanding shares of the Company, calculated on a partially converted basis (i.e., assuming the conversion of all rights to receive common shares of the Company held by the warrant holder). In connection with the Offering and as compensation for the Advisor’s services, the Company issued to the Advisor convertible debentures equal to $58,000 and convertible into 89,320 common shares and with other terms also substantially the same as the investors. The Company received cash proceeds of $575,000 from the Offering, and a participant of the offering, a related party, paid directly $150,000 to a financial consultant for a prepayment of future services to the Company. The Company intends to use the remaining proceeds from the Offering for general corporate and working capital purposes.
|
|
•
|
On October 31, 2019, the Company entered into a conversion agreement by and among the Company, HVE and Overland, a related party, under which Overland agreed to convert the following debt, accrued payables and prepayment of future goods and services into 1,600,000 Series C Preferred Shares of the Company valued at $1.00 per share: (i) principal and accrued interest of
$520,000
under the Secured Promissory Note dated November 13, 2018 by and among the Company, HVE and Overland; (ii) accrued fees of
$632,000
under the Transition Service Agreement (“TSA”) dated November 13, 2018 by and among the Company and Overland; and (iii) prepayment of $448,000 for future goods and services under the TSA.
|
|
•
|
On October 30, 2019, the directors of the Company passed a resolution authorizing the filing of articles of amendment to create a third series of preferred shares, being, an unlimited number of Series C Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. On November 6, 2019, the Company filed Articles of Amendment to create the Series C Preferred Shares.
|
|
•
|
On October 30, 2019, the Company entered into a related party subscription agreement and issued 330,000 common shares of the Company at $1.07 per share to a vendor in exchange for the satisfaction of certain accounts payable. The aggregate amount of the obligations shall be reduced by the cash proceeds actually received by the vendor from the sale of the shares by the vendor.
|
|
•
|
On October 30, 2019, the Company entered into a letter of intent with O’Melveny & Myers LLP (“OMM”) to address the matter of $1.7 million of outstanding invoices, included in accounts payable at December 31, 2019, for legal services previously provided by OMM. The Company intends to issue a secured promissory note at the reduced amount of $1.1 million to OMM in satisfaction of such liabilities. As of December 31, 2019, no such promissory note has been issued.
|
|
•
|
On October 9, 2019, the Company entered into a subscription agreement and issued 149,500 common shares of the Company at $1.19 to a vendor in exchange for the satisfaction of certain accounts payable. The aggregate amount of the obligations shall be reduced by the cash proceeds actually received by the vendor from the sale of the shares by the vendor.
|
|
•
|
In August 2019, the Company entered into agreements with certain executives of the Company and the Company’s Board of Directors to extinguish certain accrued liabilities. The Company wrote off
$1.7 million
of outstanding liabilities and recorded a gain on forgiveness of liabilities, which is included in other income, net.
|
|
•
|
On August 15, 2019, the Company entered into a purchase agreement for a private placement to issue
251,823
common shares of the Company, of which
175,765
common shares have been issued, at a purchase price of
$1.29
per share for gross proceeds received of
$325,000
. The Company used the proceeds from the offering for general corporate and working capital purposes.
|
|
•
|
On July 29, 2019, the Company completed a private placement and issued
240,000
common shares of the Company at a purchase price of
$2.00
per share for gross proceeds of
$480,000
. The Company used the proceeds from the offering for general corporate and working capital purposes.
|
|
•
|
On July 8, 2019, the directors of the Company passed a resolution authorizing the filing of articles of amendment to create a second series of preferred shares, being, an unlimited number of Series B Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto, and the Company filed Articles of Amendment to create the Series B Preferred Shares. The rights, privileges, restrictions and conditions attaching to the Series B Preferred Shares are substantially the same as the Series A Preferred Shares of the Company, save and except that the requirement for the Company to redeem all of the issued and outstanding Series A Preferred Shares on or before November 13, 2020 has been amended to provide that the Company shall only be required to redeem 1,000,000 Series B Preferred Shares on or before November 13, 2020 and any other outstanding Series B Preferred Shares may be redeemed at any time and from time to time after December 19, 2019 at the option of the Company.
|
|
•
|
On July 12, 2019, following the filing of the Articles of Amendment to create the Series B Preferred Shares, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with FBC Holdings to exchange the 6,500,000 Series A Preferred Shares held by FBC Holdings for 6,500,000 Series B Preferred Shares. On October 31, 2019, FBC Holdings, as the sole shareholder of Series B Shares, irrevocably waived its entitlement to the required redemption of 1,000,000 Series B Preferred Shares.
|
|
•
|
On July 12, 2019, in connection with the Share Exchange Agreement, the Company entered into an amendment to the Exchange and Buy-Out Agreement by and among the Company, FBC Holdings, SVTP and MF Ventures LLC (“MFV”) such that the rights and obligations under the Exchange and Buy-Out Agreement would apply to the Series B Preferred Shares in respect of which the Series A Preferred Shares were exchanged under the Share Exchange Agreement.
|
|
|
Year Ended December 31,
|
||||
|
|
2019
|
|
2018
|
||
|
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenue
|
66.8
|
|
|
81.4
|
|
|
Gross profit
|
33.2
|
|
|
18.6
|
|
|
Operating expenses:
|
|
|
|
||
|
Sales and marketing
|
32.8
|
|
|
37.4
|
|
|
Research and development
|
36.8
|
|
|
37.9
|
|
|
General and administrative
|
70.4
|
|
|
83.0
|
|
|
Impairment of acquired intangible assets
|
1.3
|
|
|
—
|
|
|
|
141.3
|
|
|
158.3
|
|
|
Loss from operations
|
(108.1
|
)
|
|
(139.7
|
)
|
|
Interest expense
|
(6.3
|
)
|
|
(0.8
|
)
|
|
Other income, net
|
37.6
|
|
|
0.1
|
|
|
Net loss from continuing operations
|
(76.8
|
)
|
|
(140.4
|
)
|
|
Net loss from discontinued operations
|
—
|
|
|
(149.7
|
)
|
|
Net loss
|
(76.8
|
)%
|
|
(290.1
|
)%
|
|
|
Year Ended December 31,
|
|
|
|||||||
|
|
2019
|
|
2018
|
|
Change
|
|||||
|
Disk systems
|
$
|
3,086
|
|
|
$
|
6,108
|
|
|
(49.5
|
)%
|
|
Service
|
2,493
|
|
|
2,922
|
|
|
(14.7
|
)%
|
||
|
Total
|
$
|
5,579
|
|
|
$
|
9,030
|
|
|
(38.2
|
)%
|
|
|
Year Ended December 31,
|
|
|
|||||||
|
|
2019
|
|
2018
|
|
Change
|
|||||
|
Americas
|
$
|
5,023
|
|
|
$
|
8,044
|
|
|
(37.6
|
)%
|
|
APAC
|
356
|
|
|
534
|
|
|
(33.3
|
)%
|
||
|
EMEA
|
200
|
|
|
452
|
|
|
(55.8
|
)%
|
||
|
Total
|
$
|
5,579
|
|
|
$
|
9,030
|
|
|
(38.2
|
)%
|
|
|
|
Year Ended December 31,
|
|
|
|||||||
|
|
|
2019
|
|
2018
|
|
Change
|
|||||
|
Gross profit
|
|
$
|
1,854
|
|
|
$
|
1,679
|
|
|
10.4
|
%
|
|
Gross margin
|
|
33.2
|
%
|
|
18.6
|
%
|
|
14.6
|
pt
|
||
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Net cash used in operating activities
|
|
$
|
(1,813
|
)
|
|
$
|
(7,621
|
)
|
|
Net cash provided by investing activities
|
|
$
|
—
|
|
|
$
|
944
|
|
|
Net cash provided by financing activities
|
|
$
|
1,621
|
|
|
$
|
2,444
|
|
|
Contractual Obligations
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
After 5
years
|
||||||||||
|
Line of credit
|
|
491
|
|
|
491
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Purchase obligations
(1)
|
|
47
|
|
|
47
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total contractual obligations
|
|
$
|
538
|
|
|
$
|
538
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
(1)
|
Represents purchase orders for inventory and non-inventory items entered into prior to
December 31, 2019
, with purchase dates extending beyond January 1, 2020. Some of these purchase obligations may be canceled.
|
|
Name
|
|
Age
|
|
Director Since
|
|
Positions with our Company
|
|
|
|
|
|
|
|
|
|
Cheemin Bo-Linn
(1)
|
|
66
|
|
April 17, 2017
|
|
Director, Chair of Audit Committee
|
|
Vivekanand Mahadevan
(1)
|
|
66
|
|
December 1, 2014
|
|
Director, Chair of Nominating and Governance Committee
|
|
Duncan J. McEwan
(1)
|
|
66
|
|
May 10, 2017
|
|
Director, Chair of Compensation Committee
|
|
Peter Tassiopoulos
|
|
51
|
|
March 7, 2014
|
|
Chief Executive Officer and Director
|
|
Kurt L. Kalbfleisch
(2)
|
|
54
|
|
N/A
|
|
Senior Vice President, Chief Financial Officer and Secretary
|
|
Joseph L. O’Daniel
|
|
49
|
|
N/A
|
|
President
|
|
(1)
|
Member of Audit Committee, Compensation Committee and Nominating and Governance Committee.
|
|
(2)
|
Mr. Kalbfleisch has served as Senior Vice President and Chief Financial Officer of the Company since December 1, 2014, and is now serving in these positions in an interim role since the divestiture of Overland Storage, Inc. and its subsidiaries (“Overland”) on November 13, 2018 while the Company looks for his replacement. In November 2018, the Company entered into a transition services agreement with Overland, under which Mr. Kalbfleisch is providing ongoing services to the Company as its interim chief financial officer.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Share- based Awards
($)
|
|
Non-equity Incentive Plan Compensation
($)
|
|
All Other Compensation(1)
($)
|
|
Total Compensation
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter Tassiopoulos
(2)
|
|
2019
|
|
233,083
|
|
—
|
|
—
|
|
4,744
|
|
237,827
|
|
Chief Executive Officer
|
|
2018
|
|
239,938
|
|
—
|
|
—
|
|
404,831
|
(3)
|
644,769
|
|
Kurt L. Kalbfleisch
(4)
|
|
2019
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Senior Vice President and
Chief Financial Officer
|
|
2018
|
|
300,000
|
|
—
|
|
—
|
|
522,828
|
(5)
|
822,828
|
|
Joseph L. O’Daniel
|
|
2019
|
|
200,000
|
|
—
|
|
—
|
|
3,351
|
|
203,351
|
|
President
|
|
2018
|
|
200,000
|
|
181,284
|
(6)
|
—
|
|
11,856
|
|
393,140
|
|
(1)
|
The amounts shown in the “All Other Compensation” column reflect amounts we paid on each named executive officers’ behalf for health insurance and life insurance premiums and certain out-of-pocket medical expenses, unless otherwise footnoted.
|
|
(2)
|
The dollar amounts reported for Mr. Tassiopoulos in the above table are presented after conversion from Canadian dollars to U.S. dollars. For 2019 and 2018, the average U.S. dollar to Canadian dollar conversion rate in effect was 1.33 and 1.29, respectively.
|
|
(3)
|
This amount includes accrued severance and change of control benefits in the amount of $400,000 that may be payable to Mr. Tassiopoulos under the compensation arrangements described below as a result of the Overland divestiture. In August 2019, Mr. Tassiopoulos waived his entitlement to receive the change of control payment and agreed to restructure such payment entitlement on the terms set forth in his new employment agreement with the Company described below under “Executive Officer Compensation.”
|
|
(4)
|
Mr. Kalbfleisch received no compensation from the Company in 2019. Since the Overland divestiture in November 2018, Mr. Kalbfleisch serves as the Company’s Senior Vice President and Chief Financial Officer pursuant to a transition services agreement with Overland.
|
|
(5)
|
This amount includes certain expenses reimbursed by the Company for a vacation that Mr. Kalbfleisch was required to cancel during 2018 and an additional payment by the Company to cover his tax liabilities with respect to these reimbursed expenses. This amount also includes accrued severance and change of control benefits in the amount of $450,000 that may be payable to Mr. Kalbfleisch under the compensation arrangements described below as a result of the Overland divestiture. In August 2019, Mr. Kalbfleisch agreed to reduce his change of control benefit to $360,000 and agreed to restructure such payment entitlement on the terms set forth under a new change of control agreement with the Company described below under “Executive Officer Compensation.”
|
|
(6)
|
This is a restricted stock award which was granted on February 20, 2018 and was valued at $18.72 per share on the grant date (the closing market price for a share of our common stock on that date).
|
|
Name
|
|
|
|
Option-based Awards
|
||||||||||
|
|
Grant Date
|
|
Number of Securities
Underlying
Unexercised Options (#)
|
Number of Securities
Underlying
Unexercised Options (#)
|
|
Option Exercise Price
($)
|
Option Expiration Date
|
|||||||
|
|
Exercisable
|
Unexercisable
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Peter Tassiopoulos
|
|
9/16/2013
|
|
500
|
|
|
—
|
|
|
|
403.01
|
|
(1)
|
9/15/2023
|
|
Kurt L. Kalbfleisch
|
|
8/26/2015
|
|
500
|
|
|
—
|
|
|
|
542.00
|
|
|
8/26/2021
|
|
(1)
|
The exercise price reported for Mr. Tassiopoulos in the table above is presented after conversion from Canadian dollars to U.S. dollars based on an exchange rate of 1.33 Canadian dollars to one U.S. dollar, which is the average conversion rate in effect for 2019.
|
|
Name
|
|
Fees Earned
($)
|
|
Stock Awards(1)
($)
|
|
All Other Compensation
($)
|
|
Total
($)
|
|
|
|
|
|
|
|
|
|
|
|
Cheemin Bo-Linn
|
|
50,000
|
|
—
|
|
—
|
|
50,000
|
|
Vivekanand Mahadevan
|
|
50,000
|
|
—
|
|
—
|
|
50,000
|
|
Duncan J. McEwan
|
|
40,000
|
|
—
|
|
—
|
|
40,000
|
|
(1)
|
At the end of fiscal
2019
, our non-employee directors did not have any outstanding equity awards.
|
|
Plan Category
|
|
(a)
Number of
Common Shares
to be Issued
Upon Exercise
of Outstanding
Options and Rights
|
|
(b)
Weighted-average
Exercise Price
of Outstanding
Options and
Rights
(1)
|
|
(c)
Number of Common
Shares Remaining
Available for Future
Issuance Under
Equity Compensation
Plans (Excluding
Shares Reflected
in Column (a))
|
||
|
|
|
|
|
|
|
|
||
|
Equity compensation plans approved by our shareholders
(2)
|
|
2,685
|
|
|
$766.59
|
|
233,368
|
|
|
Equity compensation plans not approved by our shareholders
(3)
|
|
20,713
|
|
|
—
|
|
—
|
|
|
Total
|
|
23,398
|
|
|
|
|
233,368
|
|
|
(1)
|
The weighted-average exercise prices do not reflect shares subject to outstanding awards of restricted stock units.
|
|
(2)
|
Of the aggregate number of shares that are to be issued upon exercise of outstanding options and rights as reported in column (c), 195,868 were available under the 2015 Plan and 37,500 were available under the ESPP. The 2015 Plan permits the granting of the following types of incentive awards: stock options, stock appreciation rights, restricted shares, and stock units.
|
|
(3)
|
These figures represent stock units (the “Inducement Stock Units”) granted to certain employees as an inducement to their commencing employment with us as provided under the Nasdaq listing rules. The Inducement Stock Units are generally subject to the same terms as stock units granted under the 2015 Plan. The Inducement Stock Units vest over three years and are subject to earlier termination in the case of termination of the employee’s employment or a change in control of the Company.
|
|
Beneficial Owner
(1)
|
|
Number of Shares Beneficially Owned
(2)
|
|
Percent
(3)
|
|
|
|
|
|
|
|
|
|
Brian K. McWilliams
|
|
397,320
|
|
(4)
|
8.2%
|
|
105 Harrison Garden Boulevard, Suite GV105
|
|
|
|
|
|
|
Toronto, Ontario M2N 0C3
|
|
|
|
|
|
|
Peter Tassiopoulos
|
|
1,000
|
|
(5)
|
*
|
|
Kurt L. Kalbfleisch
|
|
18,885
|
|
(5)
|
*
|
|
Joseph L. O'Daniel
|
|
10,625
|
|
|
*
|
|
Cheemin Bo-Linn
|
|
4,544
|
|
|
*
|
|
Duncan J. McEwan
|
|
3,596
|
|
|
*
|
|
Vivekanand Mahadevan
|
|
3,185
|
|
|
*
|
|
Current directors and executive officers as a group (6 persons)
|
|
41,835
|
|
(6)
|
*
|
|
(1)
|
Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all common shares shown as beneficially owned by them. Unless otherwise noted, the address for each beneficial owner is: c/o Sphere 3D Corp., 895 Don Mills Road, Bldg.2, Suite 900, Toronto, Ontario, Canada M3C 1W3.
|
|
(2)
|
Under the rules of the Securities and Exchange Commission, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or warrants and vesting of stock awards.
|
|
(3)
|
Calculated on the basis of
4,597,405
shares of common stock outstanding as of
May 6, 2020
, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after
May 6, 2020
are deemed to be outstanding for the purpose of calculating that stockholder’s percentage beneficial ownership.
|
|
(4)
|
These shares include 77,000 common shares and the right to acquire 89,320 common shares upon conversion of a debenture held by Torrington Financial Services Limited (“Torrington”) and 97,020 common shares and the right to acquire 133,980 common shares upon conversion of a debenture held by Lallande Poydras Investment Partnership (“Lallande”). Mr. McWilliam is the Chief Executive Officer and a Director of Torrington and a Managing Partner of Lallande and as such has investment and voting power over these shares. These shares do not include the right to acquire 77,000 shares upon the exercise of a warrant held by Torrington or the right to acquire 231,000 shares upon the exercise of a warrant held by Lallande because both warrants include a provision which prevents the warrant holder from exercising the warrant if the number of shares held by the warrant holder after exercise would equal or exceed 5% of the outstanding shares of the Company.
|
|
(5)
|
These shares include the right to acquire shares upon exercise of 500 stock options.
|
|
(6)
|
These shares include the right to acquire shares upon exercise of 1,000 stock options beneficially owned by our executive officers.
|
|
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
|
||||
|
Audit fees
(1)
|
|
$
|
23
|
|
|
$
|
—
|
|
|
Audit related fees
(2)
|
|
—
|
|
|
—
|
|
||
|
Tax fees
(3)
|
|
—
|
|
|
—
|
|
||
|
All other fees
(4)
|
|
—
|
|
|
—
|
|
||
|
|
|
$
|
23
|
|
|
$
|
—
|
|
|
(1)
|
Audit fees consist of fees billed for professional services rendered in connection with the audit of our annual consolidated financial statements, which were provided in connection with statutory and regulatory filings or engagements. In 2019, the primary auditor changed from Moss Adams LLP to Smythe LLP.
|
|
(2)
|
Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements, and are not reported under audit fees.
|
|
(3)
|
Tax fees consist of fees billed for professional services rendered for IRS Section 302 net operating loss limitation study.
|
|
(4)
|
All other fees consist of fees for products and services other than the services reported above. There were no such services rendered to us.
|
|
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
|
||||
|
Audit fees
(1)
|
|
$
|
32
|
|
|
$
|
482
|
|
|
Audit related fees
(2)
|
|
1
|
|
|
46
|
|
||
|
Tax fees
(3)
|
|
—
|
|
|
30
|
|
||
|
All other fees
(4)
|
|
—
|
|
|
—
|
|
||
|
|
|
$
|
33
|
|
|
$
|
558
|
|
|
(1)
|
Audit fees consist of fees billed for professional services rendered in connection with the audit of our annual consolidated financial statements, which were provided in connection with statutory and regulatory filings or engagements. In 2019, the primary auditor changed from Moss Adams LLP to Smythe LLP.
|
|
(2)
|
Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements, and are not reported under audit fees.
|
|
(3)
|
Tax fees consist of fees billed for professional services rendered for IRS Section 302 net operating loss limitation study.
|
|
(4)
|
All other fees consist of fees for products and services other than the services reported above. There were no such services rendered to us.
|
|
Reports of Independent Registered Public Accounting Firms
|
|
|
|
Consolidated Balance Sheets as of December 31, 2019 and 2018
|
|
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2019 and 2018
|
|
|
|
Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2019 and 2018
|
|
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2019 and 2018
|
|
|
|
Consolidated Statements of Shareholders' Equity (Deficit) for the Years Ended December 31, 2019 and 2018
|
|
|
|
Notes to Consolidated Financial Statements
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
|
|
1.1
|
|
8-K
|
001-36532
|
4/17/2018
|
|
|
|
|
|
|
|
|
|
2.1*
|
|
8-K
|
001-36532
|
2/21/2018
|
|
|
|
|
|
|
|
|
|
2.2
|
|
8-K
|
001-36532
|
8/21/2018
|
|
|
|
|
|
|
|
|
|
2.3
|
|
8-K
|
001-36532
|
11/2/2018
|
|
|
|
|
|
|
|
|
|
3.1
|
|
6-K
|
001-36532
|
3/25/2015
|
|
|
|
|
|
|
|
|
|
3.2
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.3
|
|
8-K
|
001-36532
|
10/2/2018
|
|
|
|
|
|
|
|
|
|
3.4
|
|
8-K
|
001-36532
|
11/5/2018
|
|
|
|
|
|
|
|
|
|
3.5
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
3.6
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
|
|
3.7
|
|
8-K
|
001-36532
|
11/8/2019
|
|
|
|
|
|
|
|
|
|
3.8
|
|
8-K
|
001-36532
|
5/8/2020
|
|
|
|
|
|
|
|
|
|
3.9
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.10
|
|
6-K
|
001-36532
|
5/12/2017
|
|
|
|
|
|
|
|
|
|
4.1
|
|
F-3
|
333-210735
|
4/13/2016
|
|
|
|
|
|
|
|
|
|
4.2
|
|
6-K
|
001-36532
|
6/2/2015
|
|
|
|
|
|
|
|
|
|
4.3
|
|
6-K
|
001-36532
|
8/15/2017
|
|
|
|
|
|
|
|
|
|
4.4
|
|
8-K
|
001-36532
|
4/17/2018
|
|
|
|
|
|
|
|
|
|
4.5
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
|
|
4.6
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
|
|
4.7
|
|
8-K
|
001-36532
|
5/4/2020
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
4.8
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1
|
|
8-K
|
001-36532
|
5/14/2019
|
|
|
|
|
|
|
|
|
|
10.2
|
|
8-K
|
001-36532
|
8/21/2019
|
|
|
|
|
|
|
|
|
|
10.3
|
|
10-Q
|
001-36532
|
11/14/2019
|
|
|
|
|
|
|
|
|
|
10.4
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.5
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.6
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.7
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.8
|
|
10-Q
|
001-36532
|
11/14/2019
|
|
|
|
|
|
|
|
|
|
10.9
|
|
10-K
|
001-36532
|
4/1/2019
|
|
|
|
|
|
|
|
|
|
10.10
|
|
10-Q
|
001-36532
|
8/14/2019
|
|
|
|
|
|
|
|
|
|
10.11
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.12
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
|
|
10.13
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
|
|
10.14
|
|
10-K
|
001-36532
|
4/1/2019
|
|
|
|
|
|
|
|
|
|
10.15
|
|
10-Q
|
001-36532
|
11/14/2019
|
|
|
|
|
|
|
|
|
|
10.16
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.17
|
|
F-4
|
333-197569
|
7/23/2014
|
|
|
|
|
|
|
|
|
|
10.18
|
|
10-Q
|
001-36532
|
5/15/2019
|
|
|
|
|
|
|
|
|
|
10.19
|
|
S-8
|
333-209251
|
2/1/2016
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
|
|
10.20
|
|
S-8
|
333-209251
|
2/1/2016
|
|
|
|
|
|
|
|
|
|
10.21+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.22
|
|
S-8
|
333-205236
|
1/29/2018
|
|
|
|
|
|
|
|
|
|
10.23+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.24+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.25+
|
|
10-K
|
001-36532
|
4/1/2019
|
|
|
|
|
|
|
|
|
|
10.26
|
|
10-K
|
001-36532
|
4/1/2019
|
|
|
|
|
|
|
|
|
|
10.27+
|
|
8-K
|
001-36532
|
8/21/2019
|
|
|
|
|
|
|
|
|
|
10.28+
|
|
10-Q
|
001-36532
|
11/14/2019
|
|
|
|
|
|
|
|
|
|
10.29+
|
|
10-Q
|
001-36532
|
11/14/2019
|
|
|
|
|
|
|
|
|
|
10.30+
|
|
10-Q
|
001-36532
|
11/14/2019
|
|
|
|
|
|
|
|
|
|
10.31
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
|
|
10.32
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.33
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.34
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.35
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.36
|
|
8-K
|
001-36532
|
5/4/2020
|
|
|
|
|
|
|
|
|
|
14.1
|
|
6-K
|
001-36532
|
4/1/2015
|
|
|
|
|
|
|
|
|
|
16.1
|
|
8-K
|
001-36532
|
7/31/2019
|
|
|
|
|
|
|
|
|
|
21.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
23.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase
|
X
|
|
|
|
|
Sphere 3D Corp.
|
|
|
|
/s/ Peter Tassiopoulos
|
|
Peter Tassiopoulos
|
|
Chief Executive Officer
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ P
ETER
T
ASSIOPOULOS
|
|
Chief Executive Officer (Principal Executive Officer)
|
|
May 13, 2020
|
|
Peter Tassiopoulos
|
|
|
|
|
|
|
|
|
|
|
|
/s/ K
URT
L. K
ALBFLEISCH
|
|
Chief Financial Officer (Principal Financial and Accounting Officer)
|
|
May 13, 2020
|
|
Kurt L. Kalbfleisch
|
|
|
|
|
|
|
|
|
|
|
|
/s/ C
HEEMIN
B
O-
L
INN
|
|
Director
|
|
May 13, 2020
|
|
Cheemin Bo-Linn
|
|
|
|
|
|
|
|
|
|
|
|
/s/ V
IVEKANAND
M
AHADEVAN
|
|
Director
|
|
May 13, 2020
|
|
Vivekanand Mahadevan
|
|
|
|
|
|
|
|
|
|
|
|
/s/ D
UNCAN
J.
M
C
E
WAN
|
|
Director
|
|
May 13, 2020
|
|
Duncan McEwan
|
|
|
|
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
|
Assets
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
149
|
|
|
$
|
341
|
|
|
Accounts receivable, net
|
369
|
|
|
1,142
|
|
||
|
Inventories
|
753
|
|
|
1,230
|
|
||
|
Other current assets
|
670
|
|
|
784
|
|
||
|
Total current assets
|
1,941
|
|
|
3,497
|
|
||
|
Investment in affiliate
|
2,100
|
|
|
2,100
|
|
||
|
Property and equipment, net
|
2
|
|
|
6
|
|
||
|
Intangible assets, net
|
2,301
|
|
|
3,348
|
|
||
|
Goodwill
|
1,385
|
|
|
1,385
|
|
||
|
Other assets
|
677
|
|
|
950
|
|
||
|
Total assets
|
$
|
8,406
|
|
|
$
|
11,286
|
|
|
Liabilities and Shareholders’ Equity (Deficit)
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
4,113
|
|
|
$
|
4,600
|
|
|
Accrued liabilities
|
475
|
|
|
1,711
|
|
||
|
Accrued payroll and employee compensation
|
340
|
|
|
1,717
|
|
||
|
Deferred revenue
|
1,069
|
|
|
988
|
|
||
|
Debt, related party
|
—
|
|
|
500
|
|
||
|
Line of credit
|
491
|
|
|
100
|
|
||
|
Other current liabilities
|
158
|
|
|
23
|
|
||
|
Total current liabilities
|
6,646
|
|
|
9,639
|
|
||
|
Series A redeemable preferred shares
|
—
|
|
|
6,571
|
|
||
|
Deferred revenue, long-term
|
485
|
|
|
667
|
|
||
|
Deferred income taxes
|
16
|
|
|
16
|
|
||
|
Other non-current liabilities
|
19
|
|
|
—
|
|
||
|
Total liabilities
|
7,166
|
|
|
16,893
|
|
||
|
Commitments and contingencies (Note 15)
|
|
|
|
|
|
||
|
Shareholders’ equity (deficit):
|
|
|
|
||||
|
Series B preferred shares, no par value, unlimited shares authorized, 6,843,778 and 0 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively
|
6,844
|
|
|
—
|
|
||
|
Series C preferred shares, no par value, unlimited shares authorized, 1,600,000 and 0 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively
|
1,600
|
|
|
—
|
|
||
|
Common shares, no par value; 3,850,105 and 2,219,141 shares issued and outstanding as of December 31, 2019 and 2018, respectively
|
186,161
|
|
|
183,524
|
|
||
|
Accumulated other comprehensive loss
|
(1,769
|
)
|
|
(1,816
|
)
|
||
|
Accumulated deficit
|
(191,596
|
)
|
|
(187,315
|
)
|
||
|
Total shareholders’ equity (deficit)
|
1,240
|
|
|
(5,607
|
)
|
||
|
Total liabilities and shareholders’ equity (deficit)
|
$
|
8,406
|
|
|
$
|
11,286
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Revenue
|
$
|
5,579
|
|
|
$
|
9,030
|
|
|
Cost of revenue
|
3,725
|
|
|
7,351
|
|
||
|
Gross profit
|
1,854
|
|
|
1,679
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
Sales and marketing
|
1,831
|
|
|
3,375
|
|
||
|
Research and development
|
2,052
|
|
|
3,425
|
|
||
|
General and administrative
|
3,925
|
|
|
7,499
|
|
||
|
Impairment of acquired intangible assets
|
70
|
|
|
—
|
|
||
|
|
7,878
|
|
|
14,299
|
|
||
|
Loss from operations
|
(6,024
|
)
|
|
(12,620
|
)
|
||
|
Other income (expense):
|
|
|
|
||||
|
Interest expense, related party
|
(331
|
)
|
|
(76
|
)
|
||
|
Interest expense
|
(22
|
)
|
|
—
|
|
||
|
Other income, net
|
2,096
|
|
|
10
|
|
||
|
Net loss from continuing operations
|
(4,281
|
)
|
|
(12,686
|
)
|
||
|
Net loss from discontinued operations
|
—
|
|
|
(13,522
|
)
|
||
|
Net loss
|
$
|
(4,281
|
)
|
|
$
|
(26,208
|
)
|
|
Net loss per share:
|
|
|
|
||||
|
Continuing operations
|
$
|
(1.59
|
)
|
|
$
|
(7.65
|
)
|
|
Discontinued operations
|
—
|
|
|
(8.15
|
)
|
||
|
Net loss per share basic and diluted
|
$
|
(1.59
|
)
|
|
$
|
(15.80
|
)
|
|
Shares used in computing net loss per share:
|
|
|
|
||||
|
Basic and diluted
|
2,692,510
|
|
|
1,658,862
|
|
||
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Net loss
|
$
|
(4,281
|
)
|
|
$
|
(26,208
|
)
|
|
Other comprehensive income:
|
|
|
|
||||
|
Foreign currency translation adjustment
|
47
|
|
|
34
|
|
||
|
Foreign currency reclassification to discontinued operations
|
—
|
|
|
131
|
|
||
|
Total other comprehensive income
|
47
|
|
|
165
|
|
||
|
Comprehensive loss
|
$
|
(4,234
|
)
|
|
$
|
(26,043
|
)
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Operating activities:
|
|
|
|
||||
|
Net loss
|
$
|
(4,281
|
)
|
|
$
|
(26,208
|
)
|
|
Adjustments to reconcile net loss to cash used in operating activities:
|
|
|
|
||||
|
Forgiveness of related party liabilities
|
(1,745
|
)
|
|
—
|
|
||
|
Forgiveness of liabilities
|
(551
|
)
|
|
—
|
|
||
|
Loss on disposal of discontinued operations
|
—
|
|
|
4,281
|
|
||
|
Impairment of acquired intangible assets
|
70
|
|
|
—
|
|
||
|
Depreciation and amortization
|
1,030
|
|
|
3,857
|
|
||
|
Share-based compensation
|
637
|
|
|
1,637
|
|
||
|
Preferred shares interest expense, related party
|
291
|
|
|
—
|
|
||
|
Provision for losses on accounts receivable
|
187
|
|
|
88
|
|
||
|
Revaluation of subscription agreements
|
158
|
|
|
—
|
|
||
|
Amortization of debt issuance costs
|
—
|
|
|
1,532
|
|
||
|
Fair value adjustment of warrants
|
—
|
|
|
(259
|
)
|
||
|
Payment in-kind interest expense, related party
|
—
|
|
|
875
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
773
|
|
|
2,867
|
|
||
|
Inventories
|
477
|
|
|
645
|
|
||
|
Accounts payable and accrued liabilities
|
317
|
|
|
7,076
|
|
||
|
Accrued payroll and employee compensation
|
182
|
|
|
(933
|
)
|
||
|
Deferred revenue
|
(102
|
)
|
|
(1,221
|
)
|
||
|
Other assets and liabilities, net
|
744
|
|
|
(1,858
|
)
|
||
|
Net cash used in operating activities
|
(1,813
|
)
|
|
(7,621
|
)
|
||
|
Investing activities:
|
|
|
|
||||
|
Proceeds from divestiture
|
—
|
|
|
1,000
|
|
||
|
Purchase of property and equipment
|
—
|
|
|
(56
|
)
|
||
|
Net cash provided by investing activities
|
—
|
|
|
944
|
|
||
|
Financing activities:
|
|
|
|
||||
|
Proceeds from issuance of common shares and warrants
|
707
|
|
|
2,310
|
|
||
|
Proceeds from debt, related party
|
523
|
|
|
500
|
|
||
|
Proceeds from line of credit
|
391
|
|
|
100
|
|
||
|
Payment for issuance costs
|
—
|
|
|
(421
|
)
|
||
|
Payments on debt, related party
|
—
|
|
|
(192
|
)
|
||
|
Proceeds from exercise of outstanding warrants
|
—
|
|
|
147
|
|
||
|
Net cash provided by financing activities
|
1,621
|
|
|
2,444
|
|
||
|
Effect of exchange rate changes on cash
|
—
|
|
|
(24
|
)
|
||
|
Net decrease in cash and cash equivalents
|
(192
|
)
|
|
(4,257
|
)
|
||
|
Cash and cash equivalents, beginning of year
|
341
|
|
|
4,598
|
|
||
|
Cash and cash equivalents, end of year
|
$
|
149
|
|
|
$
|
341
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
|
Cash paid for income taxes
|
$
|
—
|
|
|
$
|
1,102
|
|
|
Cash paid for interest
|
$
|
39
|
|
|
$
|
762
|
|
|
Supplemental disclosures of non-cash investing and financing activities:
|
|
|
|
||||
|
Conversion of related party accrued interest to Series B preferred shares
|
$
|
344
|
|
|
$
|
—
|
|
|
Conversion of related party liabilities to Series C preferred shares
|
$
|
1,152
|
|
|
$
|
—
|
|
|
Issuance of Series C preferred shares for prepayment of services
|
$
|
448
|
|
|
$
|
—
|
|
|
Issuance of common shares for settlement of liabilities
|
$
|
764
|
|
|
$
|
2,160
|
|
|
Issuance of common shares for related party liabilities
|
$
|
529
|
|
|
$
|
1,393
|
|
|
Conversion of secured debt to Series A redeemable preferred shares
|
$
|
—
|
|
|
$
|
6,500
|
|
|
Costs accrued for issuance of common shares
|
$
|
—
|
|
|
$
|
174
|
|
|
|
Common Shares
|
|
Preferred Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Equity (Deficit) |
||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance at January 1, 2018
|
889,461
|
|
|
$
|
173,871
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
(1,981
|
)
|
|
$
|
(161,427
|
)
|
|
$
|
10,463
|
|
|
Adjustment to beginning retained earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
320
|
|
|
320
|
|
|||||
|
Issuance of common shares and warrants for
cash, net
|
492,600
|
|
|
2,097
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,097
|
|
|||||
|
Issuance of common shares for settlement of
related party interest expense
|
219,434
|
|
|
1,393
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,393
|
|
|||||
|
Exercise of warrants
|
26,250
|
|
|
147
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
147
|
|
|||||
|
Issuance of common shares for warrant exchange
|
178,875
|
|
|
1,364
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,364
|
|
|||||
|
Issuance of common shares pursuant to the
vesting of restricted stock units
|
71,579
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Issuance of restricted stock awards
|
340,942
|
|
|
2,160
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,160
|
|
|||||
|
Share-based compensation
|
—
|
|
|
2,492
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,492
|
|
|||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
165
|
|
|
—
|
|
|
165
|
|
|||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(26,208
|
)
|
|
(26,208
|
)
|
|||||
|
Balance at December 31, 2018
|
2,219,141
|
|
|
183,524
|
|
|
—
|
|
|
—
|
|
|
(1,816
|
)
|
|
(187,315
|
)
|
|
(5,607
|
)
|
|||||
|
Issuance of subscription agreements for payment
of liabilities
|
479,500
|
|
|
531
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
531
|
|
|||||
|
Issuance of common shares for cash
|
415,765
|
|
|
707
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
707
|
|
|||||
|
Issuance of common shares for settlement of
related party debt and interest expense
|
410,158
|
|
|
529
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
529
|
|
|||||
|
Issuance of Series B preferred shares
|
—
|
|
|
—
|
|
|
6,500,000
|
|
|
6,500
|
|
|
—
|
|
|
—
|
|
|
6,500
|
|
|||||
|
Issuance of Series C preferred shares
|
—
|
|
|
—
|
|
|
1,600,000
|
|
|
1,600
|
|
|
—
|
|
|
—
|
|
|
1,600
|
|
|||||
|
Issuance of preferred shares dividends
|
—
|
|
|
—
|
|
|
343,778
|
|
|
344
|
|
|
—
|
|
|
—
|
|
|
344
|
|
|||||
|
Issuance of common shares pursuant to the
vesting of restricted stock units
|
131,541
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Issuance of restricted stock awards
|
194,000
|
|
|
233
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
233
|
|
|||||
|
Share-based compensation
|
—
|
|
|
637
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
637
|
|
|||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
47
|
|
|
—
|
|
|
47
|
|
|||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,281
|
)
|
|
(4,281
|
)
|
|||||
|
Balance at December 31, 2019
|
3,850,105
|
|
|
$
|
186,161
|
|
|
8,443,778
|
|
|
$
|
8,444
|
|
|
$
|
(1,769
|
)
|
|
$
|
(191,596
|
)
|
|
$
|
1,240
|
|
|
1.
|
Organization and Business
|
|
2.
|
Significant Accounting Policies
|
|
3.
|
Discontinued Operations
|
|
|
|
December 31,
2018 |
||
|
Revenue of discontinued operations:
|
|
|
||
|
Product revenue
|
|
$
|
50,285
|
|
|
Service revenue
|
|
4,445
|
|
|
|
|
|
54,730
|
|
|
|
Cost of product revenue
|
|
34,493
|
|
|
|
Cost of service revenue
|
|
1,543
|
|
|
|
Gross profit of discontinued operations
|
|
18,694
|
|
|
|
Sales and marketing
|
|
10,987
|
|
|
|
Research and development
|
|
982
|
|
|
|
General and administrative
|
|
7,761
|
|
|
|
|
|
19,730
|
|
|
|
Loss from operations of discontinued operations
|
|
(1,036
|
)
|
|
|
Other expense of discontinued operations:
|
|
|
||
|
Loss on disposal of discontinued operations
|
|
(4,281
|
)
|
|
|
Interest expense, related party
|
|
(3,390
|
)
|
|
|
Interest expense
|
|
(2,321
|
)
|
|
|
Other expense
|
|
(920
|
)
|
|
|
Loss before income taxes of discontinued operations
|
|
(11,948
|
)
|
|
|
Provision for income taxes of discontinued operations
|
|
1,574
|
|
|
|
Net loss of discontinued operations
|
|
$
|
(13,522
|
)
|
|
|
|
December 31,
2018 |
||
|
Depreciation and amortization
|
|
$
|
2,137
|
|
|
Share-based compensation
|
|
$
|
855
|
|
|
Capital expenditures
|
|
$
|
64
|
|
|
4.
|
Certain Balance Sheet Items
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Raw materials
|
$
|
92
|
|
|
$
|
255
|
|
|
Work in process
|
137
|
|
|
282
|
|
||
|
Finished goods
|
524
|
|
|
693
|
|
||
|
|
$
|
753
|
|
|
$
|
1,230
|
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Transition service agreement, related party
|
$
|
345
|
|
|
$
|
—
|
|
|
Prepaid insurance and services
|
207
|
|
|
344
|
|
||
|
Deferred cost - service contracts
|
118
|
|
|
385
|
|
||
|
Other
|
—
|
|
|
55
|
|
||
|
|
$
|
670
|
|
|
$
|
784
|
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Computer equipment
(1)
|
$
|
291
|
|
|
$
|
281
|
|
|
Accumulated depreciation
(1)
|
(289
|
)
|
|
(275
|
)
|
||
|
|
$
|
2
|
|
|
$
|
6
|
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Prepaid Insurance
|
$
|
519
|
|
|
$
|
653
|
|
|
Deferred cost – service contracts
|
154
|
|
|
270
|
|
||
|
Other
|
4
|
|
|
27
|
|
||
|
|
$
|
677
|
|
|
$
|
950
|
|
|
5.
|
Investment in Affiliate
|
|
6.
|
Intangible Assets and Goodwill
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Developed technology
|
$
|
13,323
|
|
|
$
|
13,383
|
|
|
Channel partner relationships
|
730
|
|
|
730
|
|
||
|
Capitalized development costs
(1)
|
3,047
|
|
|
2,918
|
|
||
|
Customer relationships
|
380
|
|
|
380
|
|
||
|
|
17,480
|
|
|
17,411
|
|
||
|
Accumulated amortization:
|
|
|
|
||||
|
Developed technology
|
(12,682
|
)
|
|
(12,222
|
)
|
||
|
Channel partner relationships
|
(355
|
)
|
|
(233
|
)
|
||
|
Capitalized development costs
(1)
|
(2,094
|
)
|
|
(1,655
|
)
|
||
|
Customer relationships
|
(328
|
)
|
|
(303
|
)
|
||
|
|
(15,459
|
)
|
|
(14,413
|
)
|
||
|
Total finite-lived assets, net
|
2,021
|
|
|
2,998
|
|
||
|
Indefinite-lived intangible assets - trade names
|
280
|
|
|
350
|
|
||
|
Total intangible assets, net
|
$
|
2,301
|
|
|
$
|
3,348
|
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
|
7.
|
Debt
|
|
8.
|
Fair Value Measurements
|
|
Warrant liability as of January 1, 2018
|
|
$
|
1,669
|
|
|
Adoption of accounting guidance
|
|
(46
|
)
|
|
|
Change in fair value of warrants
|
|
(259
|
)
|
|
|
Reclassification to equity resulting from warrant exchange agreement
|
|
(1,364
|
)
|
|
|
Warrant liability as of December 31, 2018
|
|
$
|
—
|
|
|
9.
|
Preferred Shares
|
|
10.
|
Share Capital
|
|
Date issued
|
|
Contractual life (years)
|
|
Exercise price per share
|
|
Number outstanding
|
|
Expiration
|
|
|
May 2015
|
|
5
|
|
$800.00
|
|
4,200
|
|
|
May 31, 2020
|
|
October 2015
|
|
5
|
|
$466.00
|
|
2,010
|
|
|
October 14, 2020
|
|
December 2015
|
|
5
|
|
$500.00
|
|
5,138
|
|
|
December 15, 2020
|
|
December 2015
|
|
5
|
|
$216.00
|
|
7,500
|
|
|
December 4, 2020
|
|
March 2016
|
|
5
|
|
$500.00
|
|
150
|
|
|
March 4, 2021
|
|
August 2017
|
|
5
|
|
$42.00
|
|
37,500
|
|
|
August 11, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
11,876
|
|
|
August 16, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
25,625
|
|
|
August 22, 2022
|
|
April 2018
|
|
5
|
|
$5.60
|
|
111,563
|
|
|
April 17, 2023
|
|
|
|
|
|
|
|
205,562
|
|
(1)
|
|
|
(1)
|
Includes
37,500
of warrants to purchase common shares, in the aggregate, outstanding to related parties at
December 31, 2019
.
|
|
11.
|
Equity Incentive Plans
|
|
|
|
Shares
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term (years)
|
|
Aggregate
Intrinsic
Value
|
|||||
|
Options outstanding at January 1, 2018
|
|
23,536
|
|
|
$
|
251.20
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Exercised
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Forfeited
|
|
(3,486
|
)
|
|
$
|
132.23
|
|
|
|
|
|
||
|
Options outstanding at December 31, 2018
|
|
20,050
|
|
|
$
|
199.06
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Exercised
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Forfeited
|
|
(17,450
|
)
|
|
$
|
160.93
|
|
|
|
|
|
||
|
Options outstanding at December 31, 2019
|
|
2,600
|
|
|
$
|
781.19
|
|
|
3.5
|
|
$
|
—
|
|
|
Vested and expected to vest at December 31, 2019
|
|
2,600
|
|
|
$
|
781.19
|
|
|
3.5
|
|
$
|
—
|
|
|
Exercisable at December 31, 2019
|
|
2,600
|
|
|
$
|
781.19
|
|
|
3.5
|
|
$
|
—
|
|
|
|
Number of
Shares
|
|
Weighted Average
Grant Date Fair Value
|
|||
|
Outstanding — January 1, 2018
|
125,969
|
|
|
$
|
39.12
|
|
|
Granted
|
50
|
|
|
$
|
20.00
|
|
|
Vested and released
|
(71,579
|
)
|
|
$
|
50.88
|
|
|
Forfeited
|
(1,436
|
)
|
|
$
|
77.80
|
|
|
Outstanding — December 31, 2018
|
53,004
|
|
|
$
|
31.21
|
|
|
Granted
|
100,000
|
|
|
$
|
2.51
|
|
|
Vested and released
|
(131,541
|
)
|
|
$
|
9.68
|
|
|
Forfeited
|
(665
|
)
|
|
$
|
64.95
|
|
|
Outstanding — December 31, 2019
|
20,798
|
|
|
$
|
4.99
|
|
|
|
Number of
Shares
|
|
Weighted Average
Grant Date Fair Value
|
|||
|
Outstanding — January 1, 2018
|
—
|
|
|
$
|
—
|
|
|
Granted
|
340,942
|
|
|
$
|
6.33
|
|
|
Vested
|
(340,942
|
)
|
|
$
|
6.33
|
|
|
Outstanding — December 31, 2018
|
—
|
|
|
$
|
—
|
|
|
Granted
|
194,000
|
|
|
$
|
1.20
|
|
|
Vested
|
(194,000
|
)
|
|
$
|
1.20
|
|
|
Outstanding — December 31, 2019
|
—
|
|
|
$
|
—
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Cost of sales
|
$
|
—
|
|
|
$
|
47
|
|
|
Sales and marketing
|
279
|
|
|
310
|
|
||
|
Research and development
|
61
|
|
|
210
|
|
||
|
General and administrative
|
297
|
|
|
1,070
|
|
||
|
Total share-based compensation expense
|
$
|
637
|
|
|
$
|
1,637
|
|
|
12.
|
Net Loss per Share
|
|
|
December 31,
|
||||
|
|
2019
|
|
2018
|
||
|
Preferred shares
|
8,443,778
|
|
|
6,500,000
|
|
|
Common share purchase warrants
|
205,562
|
|
|
208,187
|
|
|
Restricted stock not yet vested or released
|
20,798
|
|
|
53,004
|
|
|
Options outstanding
|
2,600
|
|
|
20,050
|
|
|
13.
|
Income Taxes
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Domestic
|
$
|
(1,815
|
)
|
|
$
|
(11,872
|
)
|
|
Foreign
|
(2,466
|
)
|
|
(743
|
)
|
||
|
Total
|
$
|
(4,281
|
)
|
|
$
|
(12,615
|
)
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Income tax at statutory rate
|
$
|
(1,134
|
)
|
|
$
|
(3,343
|
)
|
|
Foreign rate differential
|
(77
|
)
|
|
—
|
|
||
|
Change in valuation allowance
|
15,104
|
|
|
1,329
|
|
||
|
Share-based compensation expense
|
85
|
|
|
44
|
|
||
|
Prior year true-ups
|
(13,371
|
)
|
|
111
|
|
||
|
Other differences
|
(607
|
)
|
|
1,859
|
|
||
|
Benefit from income taxes
|
$
|
—
|
|
|
$
|
—
|
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Deferred tax assets:
|
|
|
|
||||
|
Net operating loss and capital loss carryforwards
|
$
|
25,064
|
|
|
$
|
9,610
|
|
|
Intangible assets
|
2,319
|
|
|
2,280
|
|
||
|
Share-based compensation
|
28
|
|
|
52
|
|
||
|
Other
|
893
|
|
|
1,256
|
|
||
|
Deferred tax assets, gross
|
28,304
|
|
|
13,198
|
|
||
|
Valuation allowance for deferred tax assets
|
(28,246
|
)
|
|
(13,198
|
)
|
||
|
Deferred tax assets, net of valuation allowance
|
58
|
|
|
—
|
|
||
|
Deferred tax liabilities:
|
|
|
|
||||
|
Indefinite-lived intangible assets
|
(74
|
)
|
|
(16
|
)
|
||
|
Deferred tax liabilities
|
(74
|
)
|
|
(16
|
)
|
||
|
Net deferred tax liabilities
|
$
|
(16
|
)
|
|
$
|
(16
|
)
|
|
14.
|
Related Party Transactions
|
|
15.
|
Commitments and Contingencies
|
|
|
Product
Warranty |
|
Deferred
Revenue |
||||
|
Liability at January 1, 2018
|
$
|
22
|
|
|
$
|
1,537
|
|
|
Settlements made during the period
|
—
|
|
|
(1,417
|
)
|
||
|
Change in liability for warranties issued during the period
|
—
|
|
|
1,351
|
|
||
|
Change in liability for pre-existing warranties
|
—
|
|
|
—
|
|
||
|
Liability at December 31, 2018
|
22
|
|
|
1,471
|
|
||
|
Settlements made during the period
|
—
|
|
|
(1,087
|
)
|
||
|
Change in liability for warranties issued during the period
|
—
|
|
|
725
|
|
||
|
Change in liability for pre-existing warranties
|
(22
|
)
|
|
—
|
|
||
|
Liability at December 31, 2019
|
$
|
—
|
|
|
$
|
1,109
|
|
|
Current liability
|
$
|
—
|
|
|
$
|
624
|
|
|
Non-current liability
|
—
|
|
|
485
|
|
||
|
Liability at December 31, 2019
|
$
|
—
|
|
|
$
|
1,109
|
|
|
16.
|
Segmented Information
|
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Disk systems
|
|
$
|
3,086
|
|
|
$
|
6,108
|
|
|
Service
|
|
2,493
|
|
|
2,922
|
|
||
|
Total
|
|
$
|
5,579
|
|
|
$
|
9,030
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Americas
|
$
|
5,023
|
|
|
$
|
8,044
|
|
|
APAC
|
356
|
|
|
534
|
|
||
|
EMEA
|
200
|
|
|
452
|
|
||
|
Total
|
$
|
5,579
|
|
|
$
|
9,030
|
|
|
17.
|
Subsequent Events
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|